case 4: a 68-year-old man with primary myelofibrosis
Published 4 years ago • 155 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
2:08
case 1: a 68-year-old woman with primary myelofibrosis
-
10:42
treatment of primary myelofibrosis
-
2:17
case 2: a 67-year-old male with polycythemia vera
-
2:36
case 1: fedratinib treatment for myelofibrosis
-
24:12
debate: survival benefit of jak2 inhibitors in myelofibrosis
-
4:20
primary myelofibrosis: risk stratification
-
5:14
one thousand patients with primary myelofibrosis: the mayo clinic experience
-
21:52
stem cell transplant for myelofibrosis in the jak2 inhibitor era
-
25:13
update on jak inhibitors for myelofibrosis: there is more than one
-
1:24
dr klisovic on the early use of jak inhibitors in younger patients with low-risk myelofibrosis
-
2:42
the comfort-i and comfort-ii trials in myelofibrosis
-
2:59
case: 45-year-old man with hands numbness
-
6:03
survival data for patients younger than 60 with primary myleofibrosis
-
1:08
investigators study jak inhibitors in patients with myelofibrosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
1:19
dr. srdan verstovsek on jak2 inhibitors as a treatment for myelofibrosis
-
14:05
myelofibrosis: emerging jak2 inhibitor combination treatment strategies
-
16:10
stem cell transplant for myelofibrosis in the jak2 inhibitor era
-
6:20
jak inhibitor ruxolitinib comfort-ii trial shows positive results